CDH1 and cancer: CDH1 gene mutations encoding aberrant E‐cadherin proteins have been found in patients with cancer (Berx et al. 1995), which is experimentally supported by the phenotypes of a mouse model with enhanced tumorigenesis harboring a dominant negative form of E‐cadherin (Dahl et al. 1996).